ClinConnect ClinConnect Logo
Search / Trial NCT05836064

GastroBot: Artificial Intelligence Applied to Bowel Preparation

Launched by INSTITUTE OF GASTROENTEROLOGY AND ADVANCE ENDOSCOPY · Apr 18, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Bowel Preparation Colonoscopy Quality

ClinConnect Summary

The GastroBot clinical trial is studying a new artificial intelligence technology designed to help patients prepare for colonoscopy procedures more effectively. Proper bowel preparation is crucial because it helps doctors see clearly during the exam, which can improve the detection of polyps and other issues. This trial aims to see if using GastroBot can lead to better bowel cleaning compared to traditional methods of instruction. Participants will receive personalized support through a software bot that helps guide them through the preparation process, addressing any challenges they may face along the way.

To be eligible for this study, participants must be between 18 and 80 years old, understand how to use WhatsApp, and agree to take part. They should be seeking a colonoscopy for various reasons, such as screening for colon cancer or monitoring existing conditions. However, people with certain medical histories or those who have had specific surgeries may not be able to join. Those who participate can expect to receive detailed guidance and support during their bowel preparation, which could enhance their overall experience and the effectiveness of the colonoscopy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age under 18 and over 80 years old.
  • Who agrees to participate in the study and can understand and provide written informed consent.
  • Any colonoscopy indication: colorectal neoplasia screening, surveillance of colon pre-existing diseases, or diagnostic approach in symptomatic patients.
  • Smartphone owners (any device) and WhatsApp users, independence of local or international mobile phone provider.
  • Exclusion Criteria:
  • Scheduled colonoscopies with any therapeutic approach will be categorically excluded if it does not have a cecal intubation indication.
  • Patients with difficulty understanding instructions for bowel preparation or not being able to use WhatsApp.
  • History of diabetes mellitus with insulin therapy, heart disease, kidney, liver, or severe metabolic disorder.
  • Phenprocoumon therapy or severe uncontrolled coagulopathy
  • Pregnancy and lactation
  • Prior history of colon resection, ileostomy, or colostomy

About Institute Of Gastroenterology And Advance Endoscopy

The Institute of Gastroenterology and Advanced Endoscopy is a leading clinical research organization dedicated to advancing the field of gastroenterology through innovative research and the development of cutting-edge endoscopic techniques. With a focus on improving patient outcomes, the institute conducts rigorous clinical trials that explore novel therapies and diagnostic methods for gastrointestinal disorders. Committed to excellence in patient care and scientific discovery, the institute collaborates with renowned medical professionals and research institutions to enhance understanding and treatment options for patients worldwide.

Locations

Bahía Blanca, Buenos Aires, Argentina

Patients applied

0 patients applied

Trial Officials

Manuel Valero, MD

Principal Investigator

Instituto de Gastroenterología y Endoscopía de Avanzada (IGEA)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported